BrightSpring Health Services, Inc. (BTSG) Stock Analysis
Healthcare · Health Information Services · NasdaqGS
BrightSpring Health Services, Inc. (BTSG) posted $12.91B in revenue for fiscal 2025 (up 14.6% year over year), at a 1.5% net margin, and has compounded revenue about 18.7%/yr over five years, per its SEC filings.
Data last refreshed August 2, 2026 from SEC filings · how we compute this
The analyst's take on BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. has grown revenue from $7.72B to $12.91B over the last 4 fiscal years, compounding about 18.7% a year. The most recent year was up 14.6%, so growth has cooled from its longer-run pace.
Net margin sits at 1.5%, up 1.7 points year over year on a 11.8% gross margin. It carries about $2.51B of total debt.
At today's valuation the market is pricing in roughly 13.4% annual free-cash-flow growth. The one thing worth a second look in the filings is share count rising (dilution).
Synthesised from BrightSpring Health Services, Inc.'s SEC filings — descriptive, not advice. Ask the analyst your own question →
BrightSpring Health Services, Inc. revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $7.72B | $8.83B | $11.27B | $12.91B |
| Gross profit | $1.35B | $1.14B | $1.27B | $1.52B |
| Net income | $-53.91M | $-154.60M | $-18.06M | $190.67M |
| Net margin | -0.7% | -1.8% | -0.2% | 1.5% |
Source: BrightSpring Health Services, Inc. SEC filings (10-K).
BrightSpring Health Services, Inc.: 2 potential red flags in the filings
Patterns in the filed statements worth a second look — computed and cited, not AI guesswork, and not a signal to sell. The kind of thing that hides in a 10-K.
- Share count rising (dilution)Shares outstanding grew 63.0% over 2 years (117.9M → 192.1M) — existing holders' stakes are being diluted.
- Heavy debt loadTotal debt of $2612.2M is 5.3× last year's operating cash flow — it would take years of cash flow to clear.
What growth is priced into BTSG stock?
At today's market cap of $11.99B, BrightSpring Health Services, Inc. is priced for free-cash-flow growth of about 13.4% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $394.69M from the FY ending 2025-12-31). This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 4 years of BrightSpring Health Services, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track BTSG in your portfolio →
BrightSpring Health Services, Inc. financial history by metric
Compare BrightSpring Health Services, Inc. with peers
About BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
BrightSpring Health Services, Inc. — frequently asked questions
What is BrightSpring Health Services, Inc.'s revenue?
BrightSpring Health Services, Inc. (BTSG) reported revenue of $12.91B for fiscal year 2025, up 14.6% from the prior year, according to its SEC filings.
Is BrightSpring Health Services, Inc. profitable?
Yes. BTSG earned net income of $190.67M in fiscal 2025, a net margin of 1.5%.
What is BTSG's P/E ratio?
BrightSpring Health Services, Inc. trades at a price-to-earnings ratio of about 79.3 based on the latest data in our nightly-refreshed cache.
How fast is BrightSpring Health Services, Inc. growing?
BTSG's revenue grew at roughly 18.7% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does BrightSpring Health Services, Inc. have?
As of fiscal year 2025, BTSG carried roughly $2.51B in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is BrightSpring Health Services, Inc.'s gross margin?
BTSG's gross margin was 11.8% in fiscal 2025 — gross profit of $1.52B on revenue of $12.91B.
What is BrightSpring Health Services, Inc.'s market cap?
BrightSpring Health Services, Inc. (BTSG) has a market capitalization of about $11.99B, based on the latest data in our nightly-refreshed cache.
When does BrightSpring Health Services, Inc.'s fiscal year end?
BTSG's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into BTSG stock?
At today's market cap of $11.99B, BrightSpring Health Services, Inc. is priced for free-cash-flow growth of about 13.4% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $394.69M from the FY ending 2025-12-31).
Where does this data come from?
All figures are computed from BrightSpring Health Services, Inc.'s official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.